Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects - Jenkins, H; Sakurai, Y; Nishimura, A (Aliment Pharmacol Ther, 2015)
et al.